OptimizeRx OPRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.4M+4.6% | —— | —— | —— | $3.25M— | ||
| $4.73M-5.1% | —— | —— | —— | $4.99M— | ||
| $19.45M-19.1% | —— | —— | —— | $24.03M— | ||
| -$495K+77.5% | $5.02M+6,536% | $779K+109% | $1.53M+138% | -$2.2M+68.1% | ||
| $1.46M+245% | $9.65M— | $3.13M+142% | $4.26M+259% | -$1.01M+74.6% | ||
| $396K+119% | $8.57M— | $2.05M+124% | $3.19M+185% | -$2.1M+58.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is OptimizeRx's revenue?
- OptimizeRx (OPRX) generated $107.3M in revenue over the trailing twelve months, up 39.8% year over year.
- Is OptimizeRx profitable?
- OptimizeRx reported $6.8M in net income over the trailing twelve months, a 6.4% net margin.
- What are OptimizeRx's profit margins?
- Gross margin is 70.0% and operating margin is 13.2%, with a 6.4% net margin.
- What is OptimizeRx's earnings per share?
- OptimizeRx's diluted EPS over the trailing twelve months is $0.35.
- Where does OptimizeRx's income statement data come from?
- Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
